Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Open-label, Dose-escalation and Cohort Expansion Study of LUNA18 Monotherapy and Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors

NCT05012618 is registered in ClinicalTrials.gov with Chugai Pharmaceutical as lead sponsor.

NCT NCT05012618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05012618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Open-label, Dose-escalation and Cohort Expansion Study of LUNA18 Monotherapy and Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors
Lead sponsor
Chugai Pharmaceutical
Phase
Phase 1
Overall status
Terminated
Start date
October 8, 2021
Completion date
November 13, 2025
Enrollment
128 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced or metastatic solid tumors